Key result
Nisoldipine was approximately 10 times more potent than nifedipine in alleviating coronary vasoconstriction in isolated rat hearts, independent of the vasoconstrictive stimulus.
Why the study?
Does nisoldipine improve coronary relaxation compared to nifedipine in Langendorff-perfused rat hearts?
Does nisoldipine improve coronary relaxation compared to nifedipine in Langendorff-perfused rat hearts?
Answers are grounded in this paper and cite their sources.
In a rat heart model, nisoldipine demonstrated approximately 10-fold greater potency than nifedipine in reversing coronary vasoconstriction regardless of the underlying cause.
By using Langendorff-perfused rat hearts, we compared the relaxant effects of two dihydropyridine calcium antagonists (nifedipine and nisoldipine) on the coronary vasculature. Hearts were perfused at a constant flow rate (13 ml/min), and the coronary perfusion pressure was monitored to assess vasoconstriction and relaxation. Administration of 5 nM endothelin significantly increased the perfusion pressure within 5 min, and it did not decrease during the subsequent 10-min washout period. Washout with 1 nM nisoldipine or 10 nM nifedipine almost completely normalized the perfusion pressure. Administration of a nitric oxide synthase inhibitor, N(G)-nitro-L-arginine (100 microM), elevated the perfusion pressure at 5 min. When 1 nM nifedipine was added to the perfusate, it failed to decrease the pressure, but 10 and 100 nM nifedipine partly decreased it (96.4+/-8.2 and 87.0+/-8.8 mm Hg for 10 and 100 nM, respectively). Nisoldipine alleviated the pressure elevation almost completely at 10 nM (60.0+/-5.2 mm Hg). The vasodilatory effect of nisoldipine was also approximately 10 times more potent than that of nifedipine when coronary vasoconstriction was induced by hypoxia-reoxygenation. These results suggest that nisoldipine has a stronger effect than nifedipine at the organ level, which does not depend on the cause of coronary vasoconstriction.
No takes yet. Share an insight, caveat, or question.
Okada et al. (2000) studied Coronary vasoconstriction. Nisoldipine vs. Nifedipine was evaluated on Coronary perfusion pressure. Nisoldipine was approximately 10 times more potent than nifedipine in alleviating coronary vasoconstriction in isolated rat hearts, independent of the vasoconstrictive stimulus.
Synapse has enriched 10 related papers. Consider them for comparative context: